![Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days]({"type":"image" , "src" : "/sda/5944/TOC-Subject-Sample-2021-Medicine-Dentistry-Nursing-Allied-Health.jpg"})
SUMMARY
An online survey of 1,000 men with a self-reported medical diagnosis of benign prostatic hyperplasia (BPH) who had been treated or were currently being treated for their condition was conducted in order to examine adherence, discontinuation and satisfaction with treatment. Most respondents (75.1%) reported current use of at least one prescription medication. Nearly 44% of respondents reported treatment discontinuation; a self-reported severe effect of BPH on life was moderately associated with treatment discontinuation (adjusted odds ratio [OR] = 2.7,95% confidence interval [CI] 1.6–4.36), and strongly associated with treatment dissatisfaction (adjusted OR = 4.9,95% CI 2.6–9.2). Consistently 20–30% of individuals indicated that they were somewhat or very dissatisfied with the effects of treatment on specific lower urinary tract symptoms. These results suggest that a group of BPH patients, particularly those with the most severe symptoms, are underserved by current treatments.